OpenAI-Linked Biotech Startup Lands $130M to Reinvent Drug Design
By
Laura Bennett
• 1 min read
Biotech startup Chai Discovery raised $130 million in a Series B round at a $1.3 billion valuation to advance AI-driven drug discovery.